Stoke Therapeutics, Inc. (STOK)
30.47
-2.53
(-7.67%)
USD |
NASDAQ |
Dec 09, 16:00
35.07
+4.60
(+15.10%)
After-Hours: 20:00
Stoke Therapeutics Market Cap: 1.740B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.80B |
| Janux Therapeutics, Inc. | 946.73M |
| Insmed, Inc. | 41.41B |
| Sarepta Therapeutics, Inc. | 2.323B |
| Aldeyra Therapeutics, Inc. | 288.18M |
Market Cap Related Metrics
| PE Ratio | 46.17 |
| PS Ratio | 8.646 |
| Price to Book Value | 5.649 |
| Price to Free Cash Flow | 33.95 |
| Price | 30.47 |
| Earnings Yield | 2.17% |
| Operating PE Ratio | 65.38 |
| Normalized PE Ratio | 46.17 |